FDA Requests Removal of Zantac Drugs from Market
Cancer Risks Associated with Long-Term Zantac Use
Since the fall of 2019, the U.S. Food and Drug Administration (FDA) has been warning consumers about possible cancer risks associated with using Zantac and other ranitidine drugs in the long term, after independent testing revealed unacceptable levels of n-Nitrosodimethylamine (NDMA), a probable human carcinogen. As of April 1, 2020, the FDA has now formally requested a removal of all prescription and over-the-counter ranitidine drugs currently on the market, including name-brand Zantac.
Dangerous Defects: How Independent Researchers Saved the Day
In September 2019, an online pharmacy company called Valisure first alerted the FDA to a serious defect in ranitidine, which is widely used to treat heartburn, stomach acid, and ulcers. According to their Citizen Petition, lab testers found that the ranitidine molecule is inherently unstable even when manufactured correctly – and when exposed to elevated temperatures, ranitidine can react with itself to generate dangerous levels of NDMA.
Do I Have a Zantac Lawsuit?
The human body can process low levels of NDMA – which is present in many smoked and grilled meats – but lab rats have been shown to develop cancer with sustained exposure to this toxin. Already, many individuals have taken legal action against the pharmaceutical companies, claiming that Zantac directly contributed to their cancer diagnosis.
At The Ferraro Law Firm, we can help you determine if you have a lawsuit and apply over 30 years of dedicated product liability experience to your case. If you or your loved ones have been diagnosed with cancer after taking Zantac, it’s important to speak with a doctor right away and then contact an experienced personal injury attorney to review your legal options.
Contact us at (888) 554-2030 or submit our online form to get in touch with our legal team. We offer free consultations.